Compound containing imatinib and plant polysaccharide

A technology of plant polysaccharide and composition, applied in the field of medicine

Inactive Publication Date: 2018-12-18
黄泳华
View PDF4 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0009] In the prior art, there is no technical inspiration for using the combination of imatinib and plant polysaccharides to produce a synergistic anti-tumor effect

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Compound containing imatinib and plant polysaccharide
  • Compound containing imatinib and plant polysaccharide
  • Compound containing imatinib and plant polysaccharide

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0073] Example 1 Preparation of capsules comprising imatinib mesylate and ganoderma polysaccharide

[0074] Prescription (according to 100 capsules)

[0075]

[0076] Preparation

[0077] Get the prescribed amount of imatinib mesylate, ganoderma polysaccharide, microcrystalline cellulose and sodium stearyl fumarate, mix thoroughly, fill capsules, and pack separately to obtain 100 capsules.

Embodiment 2

[0078] Embodiment 2 The preparation of the capsule comprising imatinib mesylate and Yunzhi polysaccharide

[0079] Prescription (according to 100 tablets)

[0080]

[0081]

[0082] Preparation

[0083] Take the prescribed amount of imatinib mesylate, versicolor polysaccharide, microcrystalline cellulose and sodium stearyl fumarate, fully mix, and press into 100 tablets.

Embodiment 3

[0084] Example 3 Preparation of Capsules Comprising Imatinib Mesylate and Astragalus Polysaccharide

[0085] prescription

[0086]

[0087] Preparation

[0088] Take the prescribed amount of imatinib mesylate, astragalus polysaccharide, microcrystalline cellulose and sodium stearyl fumarate, mix them thoroughly, and pack them separately.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
molecular weightaaaaaaaaaa
Login to view more

Abstract

The invention provides a compound containing imatinib or pharmaceutically acceptable salt of the imatinib and plant polysaccharide. The plant polysaccharide is selected from one of ganoderma lucidum polysaccharide, coriolus versicolor polysaccharide and cynanchum otophyllum polysaccharide. Animal tests show that the compound can generate a synergistic anti-tumor effect on liver cancer, gastric cancer, a lung carcinoma model, gallbladder carcinoma and/or kidney cancer.

Description

technical field [0001] The invention relates to the technical field of medicine, in particular to a composition containing imatinib and plant polysaccharides. Background technique [0002] Imatinib (also known as STI-571, CGP57148B) is a phenylaminopyrimidine derivative with a chemical name of (4-[(4-methyl-1-piperazine)methyl]-N-[ 4-Methyl-3-{(4-(3-pyridine)2-pyrimidine)}amino]phenyl)aniline, its mesylate salt for medicinal purposes, its structural formula is shown below. [0003] [0004] Imatinib is a selective tyrosine kinase inhibitor, which inhibits its tyrosine kinase activity by competitively binding to the ATP-binding site on BCR-ABL kinase, blocking the kinase's autophosphorylation and Substrate phosphorylation level, thereby specifically inhibiting the proliferation of BCR-ABL positive cells and inducing their apoptosis. The FDA-approved indications for imatinib include hematological tumors such as chronic myeloid leukemia (CML) and solid tumors such as gastr...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/715A61P35/00A61K31/506
CPCA61K31/506A61K31/715A61P35/00A61K2300/00
Inventor 向飞周婷孙伟光黄泳华
Owner 黄泳华
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap